Wellness startup Hims launches new line of women health products

E-commerce wellness brand, Hims, after a year since its launch of male-specific wellness products, has reportedly announced its foray into women’s wellness segment by the name Hers, offering products for treating sexual wellness, skin care and hair loss among women.

As per sources, Hers, starting November, will introduce a range of new prescription hair, skin, and sexual health products for sale, costing about $15 to $100 a month. Its line of sexual health products would include a prescribed birth control pill and Addyi, the first FDA-approved drug for women suffering from hypoactive sexual desire disorder.

Reportedly, the brand’s hair products segment would include a minoxidil based cream called Rogaine and shampoo made specifically to fight hair loss, while the skin care line would include prescription topical creams for acne, antiaging and melasma.

Hilary Coles, Brand Team Leader of Hers, was quoted saying that their brand’s goal is to help women make the most informed choices about their health at every stage of their healthcare journey.

As per Forbes, Hers online platform will work similar to that of Hims, where customers can order products to show up on their doorstep on a monthly basis.

Potential patients willing to get prescription medications, for drugs like finasteride pills for fighting hair loss or birth control pills, can fill out questions about their medical history for getting clinically prescribed drugs specific for their conditions. Moreover, patients can also get their prescriptions through automated follow-up check-ins from Hims or Hers regarding their current medication or treatment.

For the record, Hims is renowned for selling medication for erectile dysfunction, oral hygiene and skin care products to men. Founded in 2017, the San Francisco-based company is reportedly backed by Redpoint Ventures, SV Angel, Founders Fund, Forerunner Ventures, 8VC and more.

Commenting on its drugs, Hers claimed that their brand’s medical advisory team has reportedly determined Addyi to be effective in reducing distress and enhancing sexual satisfaction, and believes it to be important for women to have an option for increasing sex drive as well.